Pre-Clinical Development Of Tnb-383b, A Fully Human T-Cell Engaging Bispecific Antibody Targeting Bcma For The Treatment Of Multiple Myeloma.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 21|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要